Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / July / Clobetasol Suspension Eases Cataract Inflammation
Cataract Research & Innovations News

Clobetasol Suspension Eases Cataract Inflammation

Phase 3 trials show clobetasol propionate ophthalmic suspension rapidly reduced inflammation and pain after cataract surgery

7/6/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Poll
  • Top Institutions
Top Institutions in Ophthalmology

Ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.

  • #1

    Comprehensive Eye Care Ltd.

    Washington, Missouri

    Recognized for pivotal clinical trial involvement and lead authorship on clobetasol suspension outcomes.

    Key Differentiators

    • Ophthalmology
  • #2

    Levenson Eye Associates

    Jacksonville, Florida

    Active in clinical studies related to post-cataract inflammation and clobetasol nanosuspension.

    Key Differentiators

    • Ophthalmology
  • #3

    Wilmer Eye Institute

    Baltimore, Maryland

    Conducted significant research on hormone replacement therapy and lens opacities.

    Key Differentiators

    • Ophthalmology
  • #4

    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Investigated ciprofloxacin resistance in endophthalmitis bacteria.

    Key Differentiators

    • Ophthalmology
  • #5

    Mayo Clinic

    Rochester, Minnesota

    Utilized comprehensive health records for cataract surgery research.

    Key Differentiators

    • Ophthalmology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: